APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cosmetic Efficacy Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cosmetic Efficacy Testing Market Outlook and Growth Opportunities 2026

4 June 2026210 pages

Choose your research edition.

Industry ResearchCosmetic Efficacy Testing Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Cosmetic Efficacy Testing Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Cosmetic Efficacy Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cosmetic Efficacy Testing Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Cosmetic Efficacy Testing Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Cosmetic Efficacy Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cosmetic Efficacy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cosmetic Efficacy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cosmetic Efficacy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cosmetic Efficacy Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cosmetic Efficacy Testing market include SGS, Eurofins, Measurlabs, QACS labs, Chemleg, Evalulab, QIMA Life Sciences, Intertek and Biorius, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cosmetic Efficacy Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cosmetic Efficacy Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cosmetic Efficacy Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cosmetic Efficacy Testing market.

Cosmetic Efficacy Testing Segment by Company

SGS

Eurofins

Measurlabs

QACS labs

Chemleg

Evalulab

QIMA Life Sciences

Intertek

Biorius

Oxford Biosciences

FDA

CTI

Luamed

Cosmeservice

CPT Labs

Microchem Laboratory

XCellR9

Future Cosmetics

Complife Group

Melbec Microbiology

Kirei Testing

Accugen Labs

MSL Solution

BluTest

Creative Bioarray

Iwase Cosfa

Dermaclaim Lab

Labskin

PCR

TIBD

Alliance Analytical Laboratories

Abich

HAPPI

Cosmetri

MCS

Spincontrol

Cosmetic Efficacy Testing Segment by Type

In Vitro Testing

In Vivo Testing

Cosmetic Efficacy Testing Segment by Application

Skincare Products

Haircare Products

Makeup Products

Oral Care Products

Other

Cosmetic Efficacy Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cosmetic Efficacy Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cosmetic Efficacy Testing key companies, revenue, market share, and recent developments.

3. To split the Cosmetic Efficacy Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cosmetic Efficacy Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cosmetic Efficacy Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Cosmetic Efficacy Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetic Efficacy Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cosmetic Efficacy Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetic Efficacy Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cosmetic Efficacy Testing industry.

Chapter 3: Detailed analysis of Cosmetic Efficacy Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cosmetic Efficacy Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cosmetic Efficacy Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cosmetic Efficacy Testing Industry Trends Table 2. Cosmetic Efficacy Testing Industry Drivers Table 3. Cosmetic Efficacy Testing Industry Opportunities and Challenges Table 4. Cosmetic Efficacy Testing Industry Restraints Table 5. Global Cosmetic Efficacy Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cosmetic Efficacy Testing Revenue Share by Company (2021-2026) Table 7. Global Cosmetic Efficacy Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cosmetic Efficacy Testing Key Company Manufacturing Base & Headquarters Table 9. Global Cosmetic Efficacy Testing Company, Product Type & Application Table 10. Global Cosmetic Efficacy Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cosmetic Efficacy Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In Vitro Testing Table 15. Significant Companies of In Vivo Testing Table 16. Global Cosmetic Efficacy Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cosmetic Efficacy Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cosmetic Efficacy Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cosmetic Efficacy Testing Sales Value Share by Type (2021-2026) Table 20. Global Cosmetic Efficacy Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Skincare Products Table 22. Significant Companies of Haircare Products Table 23. Significant Companies of Makeup Products Table 24. Significant Companies of Oral Care Products Table 25. Significant Companies of Other Table 26. Global Cosmetic Efficacy Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cosmetic Efficacy Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Cosmetic Efficacy Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Cosmetic Efficacy Testing Sales Value Share by Application (2021-2026) Table 30. Global Cosmetic Efficacy Testing Sales Value Share by Application (2027-2032) Table 31. Global Cosmetic Efficacy Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cosmetic Efficacy Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Cosmetic Efficacy Testing Sales Value Share by Region (2021-2026) Table 34. Global Cosmetic Efficacy Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Cosmetic Efficacy Testing Sales Value Share by Region (2027-2032) Table 36. Global Cosmetic Efficacy Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Cosmetic Efficacy Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Cosmetic Efficacy Testing Sales Value Market Share by Country (2021-2026) Table 39. Global Cosmetic Efficacy Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Cosmetic Efficacy Testing Sales Value Market Share by Country (2027-2032) Table 41. SGS Company Information Table 42. SGS Business Overview Table 43. SGS Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. SGS Cosmetic Efficacy Testing Product Portfolio Table 45. SGS Recent Development Table 46. Eurofins Company Information Table 47. Eurofins Business Overview Table 48. Eurofins Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Eurofins Cosmetic Efficacy Testing Product Portfolio Table 50. Eurofins Recent Development Table 51. Measurlabs Company Information Table 52. Measurlabs Business Overview Table 53. Measurlabs Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Measurlabs Cosmetic Efficacy Testing Product Portfolio Table 55. Measurlabs Recent Development Table 56. QACS labs Company Information Table 57. QACS labs Business Overview Table 58. QACS labs Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. QACS labs Cosmetic Efficacy Testing Product Portfolio Table 60. QACS labs Recent Development Table 61. Chemleg Company Information Table 62. Chemleg Business Overview Table 63. Chemleg Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Chemleg Cosmetic Efficacy Testing Product Portfolio Table 65. Chemleg Recent Development Table 66. Evalulab Company Information Table 67. Evalulab Business Overview Table 68. Evalulab Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Evalulab Cosmetic Efficacy Testing Product Portfolio Table 70. Evalulab Recent Development Table 71. QIMA Life Sciences Company Information Table 72. QIMA Life Sciences Business Overview Table 73. QIMA Life Sciences Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. QIMA Life Sciences Cosmetic Efficacy Testing Product Portfolio Table 75. QIMA Life Sciences Recent Development Table 76. Intertek Company Information Table 77. Intertek Business Overview Table 78. Intertek Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Intertek Cosmetic Efficacy Testing Product Portfolio Table 80. Intertek Recent Development Table 81. Biorius Company Information Table 82. Biorius Business Overview Table 83. Biorius Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Biorius Cosmetic Efficacy Testing Product Portfolio Table 85. Biorius Recent Development Table 86. Oxford Biosciences Company Information Table 87. Oxford Biosciences Business Overview Table 88. Oxford Biosciences Cosmetic Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Oxford Biosciences Cosmetic Efficacy Testing Product Portfolio Table 90. Oxford Biosciences Recent Development Table 91. FDA Company Information Table 92. FDA Business Overview Table 93. FDA Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. FDA Cosmetic Efficacy Testing Product Portfolio Table 95. FDA Recent Development Table 96. CTI Company Information Table 97. CTI Business Overview Table 98. CTI Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. CTI Cosmetic Efficacy Testing Product Portfolio Table 100. CTI Recent Development Table 101. Luamed Company Information Table 102. Luamed Business Overview Table 103. Luamed Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Luamed Cosmetic Efficacy Testing Product Portfolio Table 105. Luamed Recent Development Table 106. Cosmeservice Company Information Table 107. Cosmeservice Business Overview Table 108. Cosmeservice Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Cosmeservice Cosmetic Efficacy Testing Product Portfolio Table 110. Cosmeservice Recent Development Table 111. CPT Labs Company Information Table 112. CPT Labs Business Overview Table 113. CPT Labs Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. CPT Labs Cosmetic Efficacy Testing Product Portfolio Table 115. CPT Labs Recent Development Table 116. Microchem Laboratory Company Information Table 117. Microchem Laboratory Business Overview Table 118. Microchem Laboratory Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Microchem Laboratory Cosmetic Efficacy Testing Product Portfolio Table 120. Microchem Laboratory Recent Development Table 121. XCellR9 Company Information Table 122. XCellR9 Business Overview Table 123. XCellR9 Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. XCellR9 Cosmetic Efficacy Testing Product Portfolio Table 125. XCellR9 Recent Development Table 126. Future Cosmetics Company Information Table 127. Future Cosmetics Business Overview Table 128. Future Cosmetics Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Future Cosmetics Cosmetic Efficacy Testing Product Portfolio Table 130. Future Cosmetics Recent Development Table 131. Complife Group Company Information Table 132. Complife Group Business Overview Table 133. Complife Group Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Complife Group Cosmetic Efficacy Testing Product Portfolio Table 135. Complife Group Recent Development Table 136. Melbec Microbiology Company Information Table 137. Melbec Microbiology Business Overview Table 138. Melbec Microbiology Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Melbec Microbiology Cosmetic Efficacy Testing Product Portfolio Table 140. Melbec Microbiology Recent Development Table 141. Kirei Testing Company Information Table 142. Kirei Testing Business Overview Table 143. Kirei Testing Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Kirei Testing Cosmetic Efficacy Testing Product Portfolio Table 145. Kirei Testing Recent Development Table 146. Accugen Labs Company Information Table 147. Accugen Labs Business Overview Table 148. Accugen Labs Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Accugen Labs Cosmetic Efficacy Testing Product Portfolio Table 150. Accugen Labs Recent Development Table 151. MSL Solution Company Information Table 152. MSL Solution Business Overview Table 153. MSL Solution Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. MSL Solution Cosmetic Efficacy Testing Product Portfolio Table 155. MSL Solution Recent Development Table 156. BluTest Company Information Table 157. BluTest Business Overview Table 158. BluTest Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. BluTest Cosmetic Efficacy Testing Product Portfolio Table 160. BluTest Recent Development Table 161. Creative Bioarray Company Information Table 162. Creative Bioarray Business Overview Table 163. Creative Bioarray Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Creative Bioarray Cosmetic Efficacy Testing Product Portfolio Table 165. Creative Bioarray Recent Development Table 166. Iwase Cosfa Company Information Table 167. Iwase Cosfa Business Overview Table 168. Iwase Cosfa Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Iwase Cosfa Cosmetic Efficacy Testing Product Portfolio Table 170. Iwase Cosfa Recent Development Table 171. Dermaclaim Lab Company Information Table 172. Dermaclaim Lab Business Overview Table 173. Dermaclaim Lab Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Dermaclaim Lab Cosmetic Efficacy Testing Product Portfolio Table 175. Dermaclaim Lab Recent Development Table 176. Labskin Company Information Table 177. Labskin Business Overview Table 178. Labskin Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Labskin Cosmetic Efficacy Testing Product Portfolio Table 180. Labskin Recent Development Table 181. PCR Company Information Table 182. PCR Business Overview Table 183. PCR Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. PCR Cosmetic Efficacy Testing Product Portfolio Table 185. PCR Recent Development Table 186. TIBD Company Information Table 187. TIBD Business Overview Table 188. TIBD Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. TIBD Cosmetic Efficacy Testing Product Portfolio Table 190. TIBD Recent Development Table 191. Alliance Analytical Laboratories Company Information Table 192. Alliance Analytical Laboratories Business Overview Table 193. Alliance Analytical Laboratories Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 194. Alliance Analytical Laboratories Cosmetic Efficacy Testing Product Portfolio Table 195. Alliance Analytical Laboratories Recent Development Table 196. Abich Company Information Table 197. Abich Business Overview Table 198. Abich Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 199. Abich Cosmetic Efficacy Testing Product Portfolio Table 200. Abich Recent Development Table 201. HAPPI Company Information Table 202. HAPPI Business Overview Table 203. HAPPI Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 204. HAPPI Cosmetic Efficacy Testing Product Portfolio Table 205. HAPPI Recent Development Table 206. Cosmetri Company Information Table 207. Cosmetri Business Overview Table 208. Cosmetri Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 209. Cosmetri Cosmetic Efficacy Testing Product Portfolio Table 210. Cosmetri Recent Development Table 211. MCS Company Information Table 212. MCS Business Overview Table 213. MCS Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 214. MCS Cosmetic Efficacy Testing Product Portfolio Table 215. MCS Recent Development Table 216. Spincontrol Company Information Table 217. Spincontrol Business Overview Table 218. Spincontrol Cosmetic Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 219. Spincontrol Cosmetic Efficacy Testing Product Portfolio Table 220. Spincontrol Recent Development Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Cosmetic Efficacy Testing Product Image Figure 2. Global Cosmetic Efficacy Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cosmetic Efficacy Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Cosmetic Efficacy Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In Vitro Testing Image Figure 8. In Vivo Testing Image Figure 9. Global Cosmetic Efficacy Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cosmetic Efficacy Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cosmetic Efficacy Testing Sales Value Share by Type (2021-2032) Figure 12. Skincare Products Image Figure 13. Haircare Products Image Figure 14. Makeup Products Image Figure 15. Oral Care Products Image Figure 16. Other Image Figure 17. Global Cosmetic Efficacy Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cosmetic Efficacy Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Cosmetic Efficacy Testing Sales Value Share by Application (2021-2032) Figure 20. Global Cosmetic Efficacy Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Cosmetic Efficacy Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Cosmetic Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Cosmetic Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Cosmetic Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Cosmetic Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Cosmetic Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Cosmetic Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Cosmetic Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Cosmetic Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Cosmetic Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Cosmetic Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro Testing
  • In Vivo Testing
Applications
  • Skincare Products
  • Haircare Products
  • Makeup Products
  • Oral Care Products
  • Other
Companies covered
  • SGS
  • Eurofins
  • Measurlabs
  • QACS labs
  • Chemleg
  • Evalulab
  • QIMA Life Sciences
  • Intertek
  • Biorius
  • Oxford Biosciences
  • FDA
  • CTI
  • Luamed
  • Cosmeservice
  • CPT Labs
  • Microchem Laboratory
  • XCellR9
  • Future Cosmetics
  • Complife Group
  • Melbec Microbiology
  • Kirei Testing
  • Accugen Labs
  • MSL Solution
  • BluTest
  • Creative Bioarray
  • Iwase Cosfa
  • Dermaclaim Lab
  • Labskin
  • PCR
  • TIBD
  • Alliance Analytical Laboratories
  • Abich
  • HAPPI
  • Cosmetri
  • MCS
  • Spincontrol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cosmetic Efficacy Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cosmetic Efficacy Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cosmetic Efficacy Testing Market Dynamics
  1. 2.1 Cosmetic Efficacy Testing Industry Trends
  2. 2.2 Cosmetic Efficacy Testing Industry Drivers
  3. 2.3 Cosmetic Efficacy Testing Industry Opportunities and Challenges
  4. 2.4 Cosmetic Efficacy Testing Industry Restraints
3 Cosmetic Efficacy Testing Market by Company
  1. 3.1 Global Cosmetic Efficacy Testing Company Revenue Ranking in 2025
  2. 3.2 Global Cosmetic Efficacy Testing Revenue by Company (2021-2026)
  3. 3.3 Global Cosmetic Efficacy Testing Company Ranking (2024-2026)
  4. 3.4 Global Cosmetic Efficacy Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Cosmetic Efficacy Testing Company Product Type and Application
  6. 3.6 Global Cosmetic Efficacy Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cosmetic Efficacy Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cosmetic Efficacy Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cosmetic Efficacy Testing Market by Type
  1. 4.1 Cosmetic Efficacy Testing Type Introduction
  2. 4.1.1 In Vitro Testing
  3. 4.1.2 In Vivo Testing
  4. 4.2 Global Cosmetic Efficacy Testing Sales Value by Type
  5. 4.2.1 Global Cosmetic Efficacy Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cosmetic Efficacy Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cosmetic Efficacy Testing Sales Value Share by Type (2021-2032)
5 Cosmetic Efficacy Testing Market by Application
  1. 5.1 Cosmetic Efficacy Testing Application Introduction
  2. 5.1.1 Skincare Products
  3. 5.1.2 Haircare Products
  4. 5.1.3 Makeup Products
  5. 5.1.4 Oral Care Products
  6. 5.1.5 Other
  7. 5.2 Global Cosmetic Efficacy Testing Sales Value by Application
  8. 5.2.1 Global Cosmetic Efficacy Testing Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cosmetic Efficacy Testing Sales Value by Application (2021-2032)
  10. 5.2.3 Global Cosmetic Efficacy Testing Sales Value Share by Application (2021-2032)
6 Cosmetic Efficacy Testing Regional Value Analysis
  1. 6.1 Global Cosmetic Efficacy Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cosmetic Efficacy Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cosmetic Efficacy Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cosmetic Efficacy Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cosmetic Efficacy Testing Sales Value (2021-2032)
  7. 6.3.2 North America Cosmetic Efficacy Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cosmetic Efficacy Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Cosmetic Efficacy Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cosmetic Efficacy Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cosmetic Efficacy Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cosmetic Efficacy Testing Sales Value (2021-2032)
  16. 6.6.2 South America Cosmetic Efficacy Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cosmetic Efficacy Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cosmetic Efficacy Testing Sales Value Share by Country, 2025 VS 2032
7 Cosmetic Efficacy Testing Country-level Value Analysis
  1. 7.1 Global Cosmetic Efficacy Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cosmetic Efficacy Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cosmetic Efficacy Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cosmetic Efficacy Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cosmetic Efficacy Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cosmetic Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cosmetic Efficacy Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SGS
  2. 8.1.1 SGS Company Information
  3. 8.1.2 SGS Business Overview
  4. 8.1.3 SGS Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SGS Cosmetic Efficacy Testing Product Portfolio
  6. 8.1.5 SGS Recent Developments
  7. 8.2 Eurofins
  8. 8.2.1 Eurofins Company Information
  9. 8.2.2 Eurofins Business Overview
  10. 8.2.3 Eurofins Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Cosmetic Efficacy Testing Product Portfolio
  12. 8.2.5 Eurofins Recent Developments
  13. 8.3 Measurlabs
  14. 8.3.1 Measurlabs Company Information
  15. 8.3.2 Measurlabs Business Overview
  16. 8.3.3 Measurlabs Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Measurlabs Cosmetic Efficacy Testing Product Portfolio
  18. 8.3.5 Measurlabs Recent Developments
  19. 8.4 QACS labs
  20. 8.4.1 QACS labs Company Information
  21. 8.4.2 QACS labs Business Overview
  22. 8.4.3 QACS labs Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 QACS labs Cosmetic Efficacy Testing Product Portfolio
  24. 8.4.5 QACS labs Recent Developments
  25. 8.5 Chemleg
  26. 8.5.1 Chemleg Company Information
  27. 8.5.2 Chemleg Business Overview
  28. 8.5.3 Chemleg Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chemleg Cosmetic Efficacy Testing Product Portfolio
  30. 8.5.5 Chemleg Recent Developments
  31. 8.6 Evalulab
  32. 8.6.1 Evalulab Company Information
  33. 8.6.2 Evalulab Business Overview
  34. 8.6.3 Evalulab Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evalulab Cosmetic Efficacy Testing Product Portfolio
  36. 8.6.5 Evalulab Recent Developments
  37. 8.7 QIMA Life Sciences
  38. 8.7.1 QIMA Life Sciences Company Information
  39. 8.7.2 QIMA Life Sciences Business Overview
  40. 8.7.3 QIMA Life Sciences Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 QIMA Life Sciences Cosmetic Efficacy Testing Product Portfolio
  42. 8.7.5 QIMA Life Sciences Recent Developments
  43. 8.8 Intertek
  44. 8.8.1 Intertek Company Information
  45. 8.8.2 Intertek Business Overview
  46. 8.8.3 Intertek Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Intertek Cosmetic Efficacy Testing Product Portfolio
  48. 8.8.5 Intertek Recent Developments
  49. 8.9 Biorius
  50. 8.9.1 Biorius Company Information
  51. 8.9.2 Biorius Business Overview
  52. 8.9.3 Biorius Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biorius Cosmetic Efficacy Testing Product Portfolio
  54. 8.9.5 Biorius Recent Developments
  55. 8.10 Oxford Biosciences
  56. 8.10.1 Oxford Biosciences Company Information
  57. 8.10.2 Oxford Biosciences Business Overview
  58. 8.10.3 Oxford Biosciences Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Oxford Biosciences Cosmetic Efficacy Testing Product Portfolio
  60. 8.10.5 Oxford Biosciences Recent Developments
  61. 8.11 FDA
  62. 8.11.1 FDA Company Information
  63. 8.11.2 FDA Business Overview
  64. 8.11.3 FDA Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 FDA Cosmetic Efficacy Testing Product Portfolio
  66. 8.11.5 FDA Recent Developments
  67. 8.12 CTI
  68. 8.12.1 CTI Company Information
  69. 8.12.2 CTI Business Overview
  70. 8.12.3 CTI Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CTI Cosmetic Efficacy Testing Product Portfolio
  72. 8.12.5 CTI Recent Developments
  73. 8.13 Luamed
  74. 8.13.1 Luamed Company Information
  75. 8.13.2 Luamed Business Overview
  76. 8.13.3 Luamed Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Luamed Cosmetic Efficacy Testing Product Portfolio
  78. 8.13.5 Luamed Recent Developments
  79. 8.14 Cosmeservice
  80. 8.14.1 Cosmeservice Company Information
  81. 8.14.2 Cosmeservice Business Overview
  82. 8.14.3 Cosmeservice Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cosmeservice Cosmetic Efficacy Testing Product Portfolio
  84. 8.14.5 Cosmeservice Recent Developments
  85. 8.15 CPT Labs
  86. 8.15.1 CPT Labs Company Information
  87. 8.15.2 CPT Labs Business Overview
  88. 8.15.3 CPT Labs Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CPT Labs Cosmetic Efficacy Testing Product Portfolio
  90. 8.15.5 CPT Labs Recent Developments
  91. 8.16 Microchem Laboratory
  92. 8.16.1 Microchem Laboratory Company Information
  93. 8.16.2 Microchem Laboratory Business Overview
  94. 8.16.3 Microchem Laboratory Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Microchem Laboratory Cosmetic Efficacy Testing Product Portfolio
  96. 8.16.5 Microchem Laboratory Recent Developments
  97. 8.17 XCellR9
  98. 8.17.1 XCellR9 Company Information
  99. 8.17.2 XCellR9 Business Overview
  100. 8.17.3 XCellR9 Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 XCellR9 Cosmetic Efficacy Testing Product Portfolio
  102. 8.17.5 XCellR9 Recent Developments
  103. 8.18 Future Cosmetics
  104. 8.18.1 Future Cosmetics Company Information
  105. 8.18.2 Future Cosmetics Business Overview
  106. 8.18.3 Future Cosmetics Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Future Cosmetics Cosmetic Efficacy Testing Product Portfolio
  108. 8.18.5 Future Cosmetics Recent Developments
  109. 8.19 Complife Group
  110. 8.19.1 Complife Group Company Information
  111. 8.19.2 Complife Group Business Overview
  112. 8.19.3 Complife Group Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Complife Group Cosmetic Efficacy Testing Product Portfolio
  114. 8.19.5 Complife Group Recent Developments
  115. 8.20 Melbec Microbiology
  116. 8.20.1 Melbec Microbiology Company Information
  117. 8.20.2 Melbec Microbiology Business Overview
  118. 8.20.3 Melbec Microbiology Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Melbec Microbiology Cosmetic Efficacy Testing Product Portfolio
  120. 8.20.5 Melbec Microbiology Recent Developments
  121. 8.21 Kirei Testing
  122. 8.21.1 Kirei Testing Company Information
  123. 8.21.2 Kirei Testing Business Overview
  124. 8.21.3 Kirei Testing Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Kirei Testing Cosmetic Efficacy Testing Product Portfolio
  126. 8.21.5 Kirei Testing Recent Developments
  127. 8.22 Accugen Labs
  128. 8.22.1 Accugen Labs Company Information
  129. 8.22.2 Accugen Labs Business Overview
  130. 8.22.3 Accugen Labs Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Accugen Labs Cosmetic Efficacy Testing Product Portfolio
  132. 8.22.5 Accugen Labs Recent Developments
  133. 8.23 MSL Solution
  134. 8.23.1 MSL Solution Company Information
  135. 8.23.2 MSL Solution Business Overview
  136. 8.23.3 MSL Solution Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 MSL Solution Cosmetic Efficacy Testing Product Portfolio
  138. 8.23.5 MSL Solution Recent Developments
  139. 8.24 BluTest
  140. 8.24.1 BluTest Company Information
  141. 8.24.2 BluTest Business Overview
  142. 8.24.3 BluTest Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 BluTest Cosmetic Efficacy Testing Product Portfolio
  144. 8.24.5 BluTest Recent Developments
  145. 8.25 Creative Bioarray
  146. 8.25.1 Creative Bioarray Company Information
  147. 8.25.2 Creative Bioarray Business Overview
  148. 8.25.3 Creative Bioarray Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Creative Bioarray Cosmetic Efficacy Testing Product Portfolio
  150. 8.25.5 Creative Bioarray Recent Developments
  151. 8.26 Iwase Cosfa
  152. 8.26.1 Iwase Cosfa Company Information
  153. 8.26.2 Iwase Cosfa Business Overview
  154. 8.26.3 Iwase Cosfa Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Iwase Cosfa Cosmetic Efficacy Testing Product Portfolio
  156. 8.26.5 Iwase Cosfa Recent Developments
  157. 8.27 Dermaclaim Lab
  158. 8.27.1 Dermaclaim Lab Company Information
  159. 8.27.2 Dermaclaim Lab Business Overview
  160. 8.27.3 Dermaclaim Lab Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Dermaclaim Lab Cosmetic Efficacy Testing Product Portfolio
  162. 8.27.5 Dermaclaim Lab Recent Developments
  163. 8.28 Labskin
  164. 8.28.1 Labskin Company Information
  165. 8.28.2 Labskin Business Overview
  166. 8.28.3 Labskin Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Labskin Cosmetic Efficacy Testing Product Portfolio
  168. 8.28.5 Labskin Recent Developments
  169. 8.29 PCR
  170. 8.29.1 PCR Company Information
  171. 8.29.2 PCR Business Overview
  172. 8.29.3 PCR Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  173. 8.29.4 PCR Cosmetic Efficacy Testing Product Portfolio
  174. 8.29.5 PCR Recent Developments
  175. 8.30 TIBD
  176. 8.30.1 TIBD Company Information
  177. 8.30.2 TIBD Business Overview
  178. 8.30.3 TIBD Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  179. 8.30.4 TIBD Cosmetic Efficacy Testing Product Portfolio
  180. 8.30.5 TIBD Recent Developments
  181. 8.31 Alliance Analytical Laboratories
  182. 8.31.1 Alliance Analytical Laboratories Company Information
  183. 8.31.2 Alliance Analytical Laboratories Business Overview
  184. 8.31.3 Alliance Analytical Laboratories Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Alliance Analytical Laboratories Cosmetic Efficacy Testing Product Portfolio
  186. 8.31.5 Alliance Analytical Laboratories Recent Developments
  187. 8.32 Abich
  188. 8.32.1 Abich Company Information
  189. 8.32.2 Abich Business Overview
  190. 8.32.3 Abich Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Abich Cosmetic Efficacy Testing Product Portfolio
  192. 8.32.5 Abich Recent Developments
  193. 8.33 HAPPI
  194. 8.33.1 HAPPI Company Information
  195. 8.33.2 HAPPI Business Overview
  196. 8.33.3 HAPPI Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  197. 8.33.4 HAPPI Cosmetic Efficacy Testing Product Portfolio
  198. 8.33.5 HAPPI Recent Developments
  199. 8.34 Cosmetri
  200. 8.34.1 Cosmetri Company Information
  201. 8.34.2 Cosmetri Business Overview
  202. 8.34.3 Cosmetri Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  203. 8.34.4 Cosmetri Cosmetic Efficacy Testing Product Portfolio
  204. 8.34.5 Cosmetri Recent Developments
  205. 8.35 MCS
  206. 8.35.1 MCS Company Information
  207. 8.35.2 MCS Business Overview
  208. 8.35.3 MCS Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  209. 8.35.4 MCS Cosmetic Efficacy Testing Product Portfolio
  210. 8.35.5 MCS Recent Developments
  211. 8.36 Spincontrol
  212. 8.36.1 Spincontrol Company Information
  213. 8.36.2 Spincontrol Business Overview
  214. 8.36.3 Spincontrol Cosmetic Efficacy Testing Revenue and Gross Margin (2021-2026)
  215. 8.36.4 Spincontrol Cosmetic Efficacy Testing Product Portfolio
  216. 8.36.5 Spincontrol Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst